National Medical Transportation Network v. Deloitte & Touche

62 Cal. App. 4th 412, 72 Cal. Rptr. 2d 720, 98 Cal. Daily Op. Serv. 2063, 98 Daily Journal DAR 2850, 1998 Cal. App. LEXIS 228
CourtCalifornia Court of Appeal
DecidedFebruary 27, 1998
DocketD024940
StatusPublished
Cited by37 cases

This text of 62 Cal. App. 4th 412 (National Medical Transportation Network v. Deloitte & Touche) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
National Medical Transportation Network v. Deloitte & Touche, 62 Cal. App. 4th 412, 72 Cal. Rptr. 2d 720, 98 Cal. Daily Op. Serv. 2063, 98 Daily Journal DAR 2850, 1998 Cal. App. LEXIS 228 (Cal. Ct. App. 1998).

Opinion

Opinion

KREMER, P. J.

Defendants Deloitte & Touche and Gordon Johns appeal a judgment after jury trial favoring plaintiff National Medical Transportation *418 Network (Medtrans) on its claims for professional negligence, breach of contract and negligent interference with prospective economic advantage. 1 Defendants claim instructional errors, evidentiary error and the lack of substantial evidentiary support for various jury findings. Finding instructional errors plus insufficient evidence of causation, we reverse the judgment.

I

Introduction

Seeking to obtain capital contributions by investors, Medtrans hired defendants as independent auditors to issue an opinion about its financial condition. After unsuccessfully seeking to resolve disagreements with Medtrans’s management about the need for adjustments to the company’s financial statements, defendants resigned without issuing an audit opinion. Although hiring successor auditors, Medtrans lost a potential $10 million capital investment.

Medtrans brought this lawsuit against defendants for committing professional negligence by withdrawing prematurely from the auditing engagement, breaching the parties’ engagement contract by not issuing an audit opinion to plaintiff, and negligently interfering with Medtrans’s prospective economic advantages with successor auditors and a potential investor by making defamatory statements impugning the honesty of Medtrans’s management.

At trial Medtrans asserted defendants’ wrongdoing caused it to lose a potential $10 million capital investment. Defendants claimed that under professional standards governing auditors they had good cause to resign from their engagement with Medtrans based upon their determinations that Medtrans’s management was uncooperative, made unreliable financial representations and impaired defendants’ independence by making threats. The parties disputed whether defendants’ resignation was with good cause. However, the trial court gave a jury instruction not mentioning good cause but indicating instead that defendants’ resignation was wrongful if unduly prejudicial to Medtrans’s interests or occurring before Medtrans had reasonable opportunity to engage a successor auditor. The jury awarded Medtrans almost $10 million in damages against defendants.

Defendants contend the jury instruction on resignation misstated the professional standard governing their conduct; Medtrans did not meet its *419 burden to show its damages were caused by defendants; admission of “baseless” testimony by Medtrans’s damages expert was prejudicial error; the jury instruction on negligent interference with prospective economic advantage lacked the necessary element of independent wrongfulness; and Medtrans did not prove all elements of its cause of action for negligent interference with prospective economic advantage.

We reverse the judgment, concluding (1) the trial court prejudicially erred in giving an incorrect jury instruction on the standard governing defendants’ resignation from their professional engagement with Medtrans; (2) the record was devoid of substantial evidence that defendants caused Medtrans’s alleged damages for breach of contract; and (3) the jury instruction on negligent interference with economic advantage omitted the tort’s “independent wrong” material element. In light of the disposition based on those issues, we do not reach defendants’ attacks on the admission of Medtrans’s damages expert’s testimony or the sufficiency of the evidence for the finding defendants negligently interfered with Medtrans’s prospective economic advantage.

II

Facts

In determining whether the court erred in instructing the jury on the standard governing defendants’ withdrawal from their professional auditing engagement with Medtrans, we view the evidence in the light most favorable to defendants. (Cf. Blackwell v. Hurst (1996) 46 Cal.App.4th 939, 943 [54 Cal.Rptr.2d 209]; Maxwell v. Powers (1994) 22 Cal.App.4th 1596, 1607 [28 Cal.Rptr.2d 62]; Bernal v. Richard Wolf Medical Instruments Corp. (1990) 221 Cal.App.3d 1326, 1338 [272 Cal.Rptr. 41].) 2

In 1988 ambulance service provider-Medtrans retained as its independent auditor the predecessor of national accounting and auditing firm Deloitte.

*420 For fiscal years ending March 31, 1988, through March 31, 1991, Deloitte audited and issued reports on Medtrans’s financial statements.

By 1992 Medtrans was highly leveraged, in need of cash and unable to pay its bills currently. Since Medtrans’s primary lender had demanded repayment of its $12 million line of credit, Medtrans was seeking a replacement lender. Although Medtrans owed almost $2 million on its payroll tax obligations and its chief financial officer spent much of his time trying to cut the company’s budget, Medtrans’s chief executive officer Roberts drew a $400,000 salary.

As a partner in Deloitte, defendant Johns supervised the audit of Medtrans’s financial statements for the fiscal year ending March 31, 1992 (fiscal 1992). At that time Medtrans’s chief executive officer Roberts and Medtrans’s president Morgan each owned 50 percent of Medtrans’s common stock.

On June 9, 1992, with the fiscal 1992 audit in progress, Medtrans’s chief financial officer Ensz resigned effective June 26, 1992.

On June 18, 1992, for the purpose of saying he could not sign a management letter attesting to the accuracy of Medtrans’s financial statements since he did not think those statements were presented fairly, Ensz initiated a meeting with 3 At the meeting Ensz alerted Johns to four or five matters relevant to the audit. Ensz said that upon informing Roberts that those matters were not properly entered in Medtrans’s journals, Roberts told Ensz to leave the journals as they were and “let’s see” if the auditors “find it.” 4 Questioning Roberts’s character for honesty because of some things Roberts advocated in presenting financial information, Ensz also stated he lacked faith in the integrity of Roberts and Medtrans’s financial statements.

Meanwhile, as the fiscal 1992 audit proceeded, Roberts sought to convince William Blair & Company (Blair) to invest capital in Medtrans. Based *421 on unaudited financial statements provided by Roberts showing $1.9-million in profits during fiscal 1992, Blair preliminarily projected Medtrans’s potential earnings in 1995 would be $5.7 million. Although those unaudited statements prepared showed fiscal 1992 earnings of $1.9 million, defendants concluded based on their own audit procedures that Medtrans actually lost about $500,000. Defendants proposed adjustments to Medtrans’s financial statements. Attempting unsuccessfully to resolve the parties’ differences, defendants worked with Medtrans for about eight weeks before eventually concluding Medtrans was stonewalling.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Shelton v. MCLP Asset Co. CA2/5
California Court of Appeal, 2024
Tesoro Refining & Marketing Co. v. Rickley CA2/2
California Court of Appeal, 2024
Sheldon Development v. SCG America Group CA4/3
California Court of Appeal, 2022
Alaniz v. Sun Pacific Shippers
California Court of Appeal, 2020
Davis v. Armacost
168 A.3d 1112 (Court of Special Appeals of Maryland, 2017)
Yale v. Bowne
9 Cal. App. 5th 649 (California Court of Appeal, 2017)
O'Brien v. AMBS Diagnostics CA2/2
California Court of Appeal, 2016
Benevolent Enterprises v. Bank of America CA 2/7
California Court of Appeal, 2015
in Re Rowland Martin
Court of Appeals of Texas, 2015
Wendy Road Storage v. Teleflex CA2/6
California Court of Appeal, 2015
J.People v. Carlsbad Unified School Dist.
California Court of Appeal, 2014
J.People v. Carlsbad Unified School Dist. CA4/1
232 Cal. App. 4th 323 (California Court of Appeal, 2014)
Holguin v. Dish Network LLC
229 Cal. App. 4th 1310 (California Court of Appeal, 2014)
Hussein v. Driver CA1/4
California Court of Appeal, 2014
Ponce v. Philco Construction CA4/3
California Court of Appeal, 2014
Barksdale v. Wilkowsky
20 A.3d 765 (Court of Appeals of Maryland, 2011)
Bay Guardian Co. v. New Times Media LLC
187 Cal. App. 4th 438 (California Court of Appeal, 2010)
Bowman v. Wyatt
186 Cal. App. 4th 286 (California Court of Appeal, 2010)
PARK 100 INVESTMENT GROUP II, LLC v. Ryan
180 Cal. App. 4th 795 (California Court of Appeal, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
62 Cal. App. 4th 412, 72 Cal. Rptr. 2d 720, 98 Cal. Daily Op. Serv. 2063, 98 Daily Journal DAR 2850, 1998 Cal. App. LEXIS 228, Counsel Stack Legal Research, https://law.counselstack.com/opinion/national-medical-transportation-network-v-deloitte-touche-calctapp-1998.